Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FR1JG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,850
Award facts
- Contract value 100% obligated
- $1,850.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,850.28 by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Botox 100-unit vials. The contract, which carries no set-aside designation, is scheduled for completion by September 10, 2025, with performance taking place at the awardee's Park Ridge, Illinois facility. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare systems.
The Botox delivery represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company maintains a robust portfolio of pharmaceutical product deliveries to military and federal healthcare facilities nationwide, spanning prescription medications, biologics, vaccines, and specialty medical consumables. As a pharmaceutical wholesaler registered in SAM.gov since 2001, DMS Pharmaceutical Group has consistently competed effectively in federal procurement markets, leveraging its woman-owned small business status to secure multiple contract awards from the DLA across diverse product categories including oncology treatments, contraceptive devices, and injectable pharmaceuticals.
Quick answers
Who was awarded contract SPE2DB25FR1JG?
SPE2DB25FR1JG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FR1JG worth?
The government has obligated $1,850 on SPE2DB25FR1JG.
Is contract SPE2DB25FR1JG an order under another contract?
Yes. SPE2DB25FR1JG is a delivery order under SPE2DB22D9251, an indefinite delivery contract.
Was contract SPE2DB25FR1JG competed?
The extent of competition for SPE2DB25FR1JG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award